通过SYK和MAPK信号,BTN2A1的向重编程M2类巨细胞和TAMs
Clément Kerneur1, Etienne Foucher2, Jaime Guillén Casas2
1ImCheck Therapeutics, R&D Department, 13009 Marseille, France; Centre de Recherche en Cancérologie de Marseille (CRCM), INSERM U1068, 13009 Marseille, France.
Cell reports
|September 26, 2024
概括
研究人员确定了布蒂罗菲林 (BTN) 2A1作为一个重编程免疫抑制M2类瘤相关巨细胞 (TAMs) 成为M1类抗癌巨细胞的目标. 用单克隆抗体向BTN2A1显示出癌症免疫治疗的前景.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
背景情况:
- 瘤相关巨细胞 (TAMs) 经常表现出一种免疫抑制的M2类表型,导致癌症预后不佳.
- 在各种癌症类型的M2类TAM中观察到Butyrophilin (BTN) 2A1的表达升高.
研究的目的:
- 研究BTN2A1在M2类TAM中的作用.
- 开发和评估抗BTN2A1单克隆抗体 (mAbs),用于将TAM重编程为一种抗瘤的M1-类表型.
主要方法:
- 开发抗BTN2A1单克隆抗体.
- 在癌症患者和健康捐赠者的TAMs体外和体外分析.
- 评估巨细胞分化,T细胞增殖和细胞因子分泌.
- 涉及SYK和ERK酸化途径的机制研究.
主要成果:
- 一个抗BTN2A1 mAb克隆有效抑制了M2类巨细胞分化,并促进了M1类表型.
- 用抗BTN2A1 mAb治疗的巨细胞显示T细胞增殖和干扰素玛 (IFNγ) 分泌增强.
- 参与BTN2A1激活了SYK和ERK信号通道,这对于M2重编程至关重要.
结论:
- BTN2A1在M2类TAMs的分化和免疫抑制功能中发挥着关键作用.
- 用特定的单克隆抗体向BTN2A1代表了通过重编程TAM来进行癌症免疫治疗的潜在新战略.
相关概念视频
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
MAPK Signaling Cascades
5.3K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.3K
Receptor Downregulation in MVBs
2.0K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.0K
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K


